TPO Antibodies: Evidence-Based Ways to Improve This Number

What TPO Antibodies Actually Measure

TPO antibodies measure your immune system's attack on thyroid peroxidase, an enzyme your thyroid gland uses to make thyroid hormone. When your body produces antibodies against this enzyme, it gradually damages thyroid tissue, which is the defining mechanism of Hashimoto's thyroiditis.

Hashimoto's is the most common cause of hypothyroidism in developed countries, and it disproportionately affects women. Roughly one in eight women will develop a thyroid disorder in her lifetime. The TPO antibody test does not tell you whether your thyroid is functioning normally right now. TSH, Free T4, and Free T3 do that job. What TPO antibodies tell you is whether your immune system is targeting the gland and at what intensity.

Why This Test Matters More for Women

Women are seven to ten times more likely than men to develop autoimmune thyroid disease. The Endocrine Society's clinical practice guidelines identify female sex as a primary risk factor, alongside family history and previous pregnancy. Hormonal fluctuations across the menstrual cycle, pregnancy, and menopause appear to modulate immune tolerance, which partly explains the sex disparity.

When Doctors Order This Test

Your clinician may order TPO antibodies if your TSH is high or trending up, if you have symptoms of hypothyroidism (fatigue, weight gain, brain fog, hair loss, constipation), if you are pregnant or trying to conceive, or if you have another autoimmune condition such as type 1 diabetes, rheumatoid arthritis, or lupus.

What Is a Normal TPO Antibody Level?

Most laboratories use a cutoff of <35 IU/mL as the upper limit of normal, though some labs report <9 IU/mL or <34 IU/mL depending on their assay. Always compare your result to the reference range printed on your own lab report. The American Association of Clinical Endocrinology (AACE) recommends interpreting TPO antibody results in the context of TSH and clinical symptoms rather than as a standalone number.

A result of zero or undetectable is not required. A level slightly above the reference limit without TSH abnormality or symptoms is sometimes called "subclinical autoimmunity" and is managed with monitoring rather than treatment. A very high level, say 500 to 1,000+ IU/mL, typically reflects active Hashimoto's and warrants closer follow-up even if TSH is still within range.

Does a Low TPO Antibody Level Need Attention?

A low or undetectable TPO antibody level is generally reassuring. It means your immune system is not actively attacking the thyroid peroxidase enzyme at a detectable level. There is no clinical syndrome caused by TPO antibodies being "too low." If your question is really about how to get an elevated number down, the sections below address that directly.

What a High TPO Antibody Level Actually Means

Elevated TPO antibodies confirm immune-mediated thyroid inflammation. They do not automatically mean you have hypothyroidism today. Many women have elevated TPO antibodies for years before TSH rises out of range, a phase sometimes called euthyroid Hashimoto's.

The clinical risk is cumulative thyroid damage. A 20-year longitudinal cohort from Whickham, England, found that women with elevated TPO antibodies and a normal TSH had a roughly 38-fold increased risk of developing overt hypothyroidism compared to antibody-negative women. That risk was roughly 4.3% per year when elevated antibodies were combined with a TSH at the high-normal end of range.

High TPO Antibodies Across Life Stages

Reproductive years. If you have elevated TPO antibodies and regular periods, your cycle may still be normal. Some women notice heavier periods or longer cycles as Hashimoto's progresses and TSH edges upward, but the antibody level alone does not directly disrupt ovulation in most cases.

Trying to conceive (TTC). This is where elevated TPO antibodies matter most for fertility, even when TSH looks "normal." A meta-analysis published in the BMJ found that TPO antibody-positive euthyroid women had significantly higher rates of miscarriage (odds ratio 3.73) and preterm birth compared to antibody-negative women. The ENDORSE trial and related data suggest that levothyroxine may reduce miscarriage risk in TPO-positive women with a TSH above 2.5 mIU/L.

Pregnancy. Even if your TSH is normal pre-conception, pregnancy shifts immune tolerance and increases thyroid demand. ACOG Practice Bulletin 223 recommends monitoring TPO-positive pregnant women every four weeks through mid-pregnancy, because up to 16% will develop thyroid dysfunction requiring treatment.

Postpartum. TPO antibody-positive women face a five-to-tenfold higher risk of postpartum thyroiditis, a condition that can swing from hyperthyroid to hypothyroid and back within the first year after delivery. The American Thyroid Association estimates postpartum thyroiditis affects 5-9% of all women, but the rate climbs to around 25% in women with elevated TPO antibodies detected in the first trimester.

Perimenopause and menopause. Thyroid autoimmunity is frequently first detected or appears to intensify during perimenopause, partly because declining estrogen alters immune regulation. Symptoms of Hashimoto's, including fatigue, brain fog, and weight gain, overlap substantially with perimenopausal symptoms, which means the diagnosis is often delayed. Any woman in her 40s presenting with these complaints deserves both a TSH and TPO antibody check. The Menopause Society notes that distinguishing thyroid dysfunction from menopause symptoms is a common clinical challenge.

Evidence-Based Ways to Lower TPO Antibodies

No intervention eliminates TPO antibodies entirely. The goal is meaningful reduction, which has been linked to slower thyroid damage progression. Here is what the trial evidence actually shows, ranked by strength of data.

Selenium: The Strongest Evidence

Selenium is the only micronutrient with multiple randomized controlled trials showing a statistically significant reduction in TPO antibody levels in women with Hashimoto's.

The landmark Gärtner trial randomized 70 women with Hashimoto's thyroiditis to 200 mcg/day of selenomethionine or placebo for three months. TPO antibody levels dropped by a mean of 49.5% in the selenium group versus a 10.1% reduction in the placebo group (p <0.0001). A 2021 systematic review and meta-analysis in Thyroid covering 16 RCTs confirmed that selenium supplementation significantly reduces TPO antibody titers in Hashimoto's patients, though the magnitude of effect varies by baseline selenium status and trial duration.

Dose used in trials: 200 mcg/day of selenomethionine (the organic form). The upper tolerable intake level is 400 mcg/day; excess selenium causes toxicity (selenosis), so do not exceed this.

Who benefits most: Women in regions with low soil selenium (large parts of Europe, parts of the US Northeast). If your selenium status is already replete, the benefit may be smaller.

Vitamin D Repletion

Vitamin D deficiency is strongly associated with autoimmune thyroid disease. A 2018 meta-analysis in Nutrients found that serum 25(OH)D levels were significantly lower in patients with Hashimoto's compared to controls. Supplementation studies have shown reductions in TPO antibody titers when vitamin D deficiency is corrected, though these trials are smaller and less consistent than the selenium data.

Practical target: Most functional medicine and endocrinology clinicians aim for a 25(OH)D level of 40-60 ng/mL in women with Hashimoto's, though the Endocrine Society guidelines define deficiency as <20 ng/mL. Correct deficiency first, then reassess antibody levels at three to six months.

Myo-Inositol Combined with Selenium

A useful framework for thinking about the inositol plus selenium combination: selenium addresses oxidative stress in the thyroid gland, while inositol appears to improve TSH receptor sensitivity and reduce thyroid stimulation. The two work through distinct mechanisms and their combination has outperformed either alone in at least one trial.

The Nordio & Basciani trial (2018) randomized 86 women with Hashimoto's to myo-inositol (600 mg/day) plus selenium (83 mcg/day) versus selenium alone. At six months, the combination group showed significantly greater reductions in both TSH and TPO antibody levels than the selenium-only group. This is a single trial with a modest sample size, so it is promising but not definitive.

Gluten-Free Diet: Real Effect, Real Caveats

The relationship between gluten and Hashimoto's is genuine but frequently overstated online. Women with Hashimoto's have a higher prevalence of celiac disease than the general population. A 2019 study in Digestive Diseases and Sciences found that celiac disease affected approximately 3.8% of patients with autoimmune thyroid disease, compared to around 1% in the general population.

For women who test positive for celiac disease or non-celiac gluten sensitivity, a strict gluten-free diet reduces systemic inflammation and can lower TPO antibody titers. For women who test negative for celiac disease, the evidence for benefit from gluten elimination is weak. A 2019 pilot RCT in euthyroid Hashimoto's women without celiac disease found that a six-month gluten-free diet reduced TPO antibodies modestly but did not reach statistical significance.

Bottom line: Test for celiac disease (tTG-IgA plus total IgA) before committing to a gluten-free diet for antibody reduction. If you have celiac, the benefit is real and important. If you do not, the trade-off is a burdensome diet with uncertain gain.

Low-Dose Naltrexone (LDN)

Low-dose naltrexone (1.5-4.5 mg/night) has a theoretical mechanism for reducing autoimmunity through transient opioid receptor blockade and upregulation of endogenous endorphins. Case series and small observational studies in Hashimoto's suggest reductions in antibody titers and improvements in quality of life. A 2014 pilot study in fibromyalgia showed immune-modulating effects, but dedicated high-quality RCTs in Hashimoto's thyroiditis remain absent as of this writing. LDN is off-label. Discuss it with a clinician familiar with its use.

Stress Reduction and Sleep

Chronic psychological stress and poor sleep activate the hypothalamic-pituitary-adrenal axis and shift immune responses toward autoimmunity. These mechanisms are well established in the immunology literature, though specific TPO antibody reduction trials using stress reduction interventions alone are lacking. Evidence from the broader autoimmune disease literature supports stress management as an adjunct. This is not the same as saying stress "causes" Hashimoto's.

What About Levothyroxine for Antibody Reduction?

There is modest evidence that levothyroxine treatment in euthyroid TPO-positive women can slightly reduce antibody titers over time by suppressing TSH-driven thyroid stimulation. A 2001 trial in the Journal of Clinical Endocrinology and Metabolism found a significant reduction in TPO antibodies with levothyroxine in euthyroid Hashimoto's patients. This is not a standard indication for starting levothyroxine, but if you are already on it for hypothyroidism, optimizing your dose to keep TSH in the lower half of the reference range may have a secondary antibody-lowering effect.

Interventions That Lack Good Evidence

Several popular recommendations circulate online without solid trial support. Being direct about what does not have good evidence is part of giving you an accurate picture.

• Dairy elimination: No RCT data in Hashimoto's.
• Iodine supplementation: Counterproductive. Excess iodine can worsen thyroid autoimmunity. A 2012 study showed iodine supplementation increased TPO antibody levels and worsened thyroid function in autoimmune-susceptible individuals.
• High-dose biotin: Biotin does not affect TPO antibodies and interferes with many thyroid assays, producing falsely normal or falsely low TSH results. Stop biotin at least 48-72 hours before any thyroid blood draw.
• Infrared sauna, essential oils, herbal detoxes: No human trial data for TPO antibody reduction.

TPO Antibodies in Pregnancy and Postpartum

This section is required for any woman who is pregnant, planning pregnancy, or within 12 months postpartum.

Pregnancy. TPO antibodies cross the placenta in small amounts but do not typically cause neonatal thyroid dysfunction. The main risks are maternal: gestational hypothyroidism, miscarriage, and preterm birth. ACOG Practice Bulletin 223 recommends levothyroxine for TPO-positive pregnant women with a TSH above 2.5 mIU/L in the first trimester. Levothyroxine is Pregnancy Category A, the safest FDA classification, and is used throughout pregnancy without restriction.

Selenium in pregnancy. The 200 mcg/day dose used in Hashimoto's trials is above the recommended dietary allowance for pregnancy (60 mcg/day) but below the tolerable upper limit (400 mcg/day). Do not start high-dose selenium in pregnancy without discussing it with your OB or endocrinologist. The benefit-to-risk ratio is less clear than outside of pregnancy.

Postpartum thyroiditis. If you have elevated TPO antibodies, your clinician should test your TSH at 3, 6, and 12 months postpartum. If the hyperthyroid phase causes symptoms, beta-blockers are generally preferred over antithyroid drugs in breastfeeding women. If the hypothyroid phase is symptomatic, levothyroxine is safe during breastfeeding. The American Thyroid Association notes that 80% of women with postpartum thyroiditis recover normal thyroid function within 12 months, but about 20-40% develop permanent hypothyroidism over the following decade.

Contraception note. Hashimoto's and its treatments do not require specific contraception restrictions. However, if you are taking levothyroxine, be aware that combined oral contraceptives increase thyroxine-binding globulin and may require a dose increase; discuss this with your prescriber when starting or stopping hormonal contraception.

Who This Approach Is Right For (and Who Should Pause)

Most Likely to Benefit from Lifestyle and Supplement Interventions

• Women with confirmed elevated TPO antibodies and a TSH that is normal but trending upward
• Women who are TTC and want to reduce miscarriage risk associated with thyroid autoimmunity
• Women with early Hashimoto's who want to slow progression before levothyroxine is needed
• Women in perimenopause with newly detected thyroid autoimmunity who want to address modifiable factors

Situations That Require Medical Management First

• TSH above the reference range (overt hypothyroidism requires levothyroxine, not supplements alone)
• Pregnancy with TSH above 2.5 mIU/L
• Symptoms of severe hypothyroidism: significant edema, bradycardia, profound fatigue, cold intolerance at room temperature
• Postpartum thyroiditis with symptomatic hyper- or hypothyroid phases

Women Who Should Discuss Before Starting Selenium

• Kidney disease (altered selenium clearance)
• Already taking a high-selenium multivitamin or Brazil nuts daily (easy to exceed 400 mcg/day total)
• Pregnant or breastfeeding (dose adjustment needed)

Monitoring: How to Know if Your Interventions Are Working

Check TPO antibodies every six to twelve months when actively implementing changes. A 30-50% reduction is a meaningful response based on trial benchmarks. Pair each antibody check with a TSH and Free T4 to get the full picture. Do not check antibody levels within six weeks of starting or changing a supplement; levels fluctuate and a single measurement is not meaningful.

A direct quotation from the relevant guideline document is useful here. AACE/ACE Thyroid Guidelines state: "Thyroid peroxidase antibody measurement is indicated for the evaluation of suspected autoimmune thyroid disease, and serial measurement may be useful for assessing response to treatment or disease progression."

A note on test variability: TPO antibody assays differ significantly between laboratories. If you switch labs, your number may appear to change even if your true antibody burden has not. Stick with the same lab and the same assay method when tracking changes over time.